Trump Administration Halts $3.7 Billion in Clean Energy Projects

Published 1 days agoXOM

Trump Administration Halts $3.7 Billion in Clean Energy Projects

The Trump administration has withdrawn over $3.7 billion in grants previously allocated for clean energy initiatives. This decisive action by the U.S. Department of Energy affects 24 projects, including a notable emissions reduction effort at Exxon Mobil's Baytown refinery in Texas. Each of these projects was set to advance carbon capture, cleaner industrial technologies, and emissions reductions but will now come to a halt.

One of the impacted projects at the Baytown refinery involved a $332 million investment towards hydrogen-based technology aimed at decreasing emissions. As Reuters highlighted, this initiative was part of a broader drive to enhance the refinery's environmental footprint. However, it is now among those eliminated, reflecting a significant shift from prior climate and environmental plans.

Energy Secretary Chris Wright explained that the decision to cancel these projects is in line with a broader fiscal efficiency initiative. This approach, according to the administration, serves national security and energy reliability goals. Despite this rationale, the move has faced criticism from those who argue it could harm U.S. competitiveness in clean technology markets and increase pollution levels, as noted by AP News. This policy change forms part of a larger reevaluation of $15 billion in clean energy projects linked to the 2021 infrastructure law, indicating a strategic pivot towards fossil fuel development.

Share this article

Twitter Facebook LinkedIn

Recent Articles

Tesla's Norwegian Sales Skyrocket as Model Y Drives Growth

Tesla's Norwegian Sales Skyrocket as Model Y Drives Growth

3 minutes agoTSLA

Tesla's car sales in Norway have soared by a staggering 213% this past May compared to the same month last year, with 2,600 vehicles sold. This impressive growth, as reported by Reuters, underscores the increasing demand for electric vehicles in a market that's rapidly transitioning away from fossil fuel-powered cars. A major factor behind this surge is the popularity of Tesla's Model Y compact SUV. The revamped version has been Norway's best-selling vehicle for the last three years, which has significantly contributed to the sales jump. For the first five months of 2025, Tesla's sales in Norway increased by 8.3% compared to the same period in 2024. Notably, electric vehicles represented 92.7% of all car sales in Norway thus far in 2025, bringing the country closer to its goal of eliminating fossil fuel vehicles altogether. Despite overall declining sales in many European markets, Tesla's performance in Norway highlights the significance of local demand and strategic offerings. Tesla is currently encouraging this momentum by providing zero-interest loans for Model Y purchases in Norway and other regions, valid until the end of June, aiming to further bolster its market presence amidst broader challenges in Europe.

Liquidia's Stock Rises Amid Regulatory and Legal Advances for YUTREPIA

Liquidia's Stock Rises Amid Regulatory and Legal Advances for YUTREPIA

49 minutes agoLQDA

Liquidia Corporation saw a boost in its stock value following significant developments concerning its inhaled treprostinil product, YUTREPIA. The timeline for the FDA's exclusivity on a competing product, Tyvaso DPI®, is set to end on May 23, 2025, opening the door for YUTREPIA's final approval shortly after, according to GlobeNewswire. This anticipated clearance adds momentum to Liquidia's market position. In a noteworthy legal advancement, a district court dismissed a cross-claim from United Therapeutics that challenged an amendment related to YUTREPIA. This decision effectively removes a critical legal obstacle and paves the way for further progress. TipRanks also highlighted this victory, which complements the FDA timeline to boost confidence in YUTREPIA's approval pathway. Liquidia is not only making strides in regulatory and legal arenas but also fortifying its finances. The company amended its financial agreement with HealthCare Royalty Partners, securing up to $100 million to support YUTREPIA's launch. Analysts, as reported by TipRanks, have maintained a 'Buy' rating, reflecting a strong belief in the company's future prospects, with a price target set at $35.00 for its stock.

Amazon Faces Increased Oversight by German Regulator

Amazon Faces Increased Oversight by German Regulator

1 hours agoAMZN

Amazon has not been found to have breached competition law in Germany, according to recent reports. The German Federal Court of Justice, in April 2024, underscored Amazon's influence by confirming the Bundeskartellamt's classification of the company as having 'paramount significance for competition across markets.' This ruling subjects Amazon to heightened scrutiny under Germany's competition laws. Back in November 2022, the Bundeskartellamt extended its investigation into Amazon under Section 19a of the German Competition Act. This was part of a broader effort to ensure that Amazon's business practices, particularly its pricing mechanisms, align with new regulations intended for larger digital platforms. Despite these ongoing investigations, Reuters has noted that there remain no specific findings regarding Amazon's pricing mechanisms breaching competition laws. These developments reflect the ongoing watchful stance of regulators towards Amazon as it navigates a regulatory landscape that is becoming increasingly stringent, especially for major digital corporations. The focus remains on ensuring compliance with amended competition laws without any recent findings against Amazon's practices in Germany.

Boeing Stock Ratings Mixed Amid Trade Tensions and Contract Wins

Boeing Stock Ratings Mixed Amid Trade Tensions and Contract Wins

Recent updates reveal mixed perspectives on Boeing's stock ratings amid significant developments. As of April 28, 2025, Bank of America maintained a 'Neutral' rating for Boeing, with a target price of $185, contradicting assertions that their rating shifted to 'Buy' due to trade deals involving the company's planes. Contrastingly, other financial institutions have shown increased optimism. Melius Research upgraded Boeing's rating to 'Buy' from 'Hold' on March 24, 2025, following the company's contract victory over Lockheed Martin for the Next Generation Air Dominance program. Similarly, in February 2025, Citigroup reaffirmed its 'Buy' rating for Boeing, setting a price target of $210 per share. Despite positive developments like the $10 billion order from the UK in May 2025, Boeing faces challenges including halted imports by China in April 2025, as reported by Axios, amid U.S. tariff tensions. This illustrates the complex trade landscape Boeing must navigate while balancing opportunities and potential risks.